Testing effectiveness (Phase 2)Looking for participantsNCT06428188
What this trial is testing
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Lupus Erythematosus Acute+1 more
Essen Biotech 60